interferon beta


Also found in: Dictionary, Thesaurus, Encyclopedia, Wikipedia.
Related to interferon beta: Interferon gamma, interferon beta 1b

in·ter·fer·on be·ta

interferon elaborated by fibroblasts and microphages in response to the same stimuli as interferon alpha; only one gene codes for this interferon.
Synonym(s): fibroblast interferon

interferon beta

n.
See beta interferon.

interferon beta

Fibroblast interferon IFN-β A 20 kD anti-viral protein with 30% 'homology' with IFN alpha, encoded on chromosome 9, produced by fibroblasts in response to viruses or polyribonucleotides

interferon beta

A INTERFERON used as a drug to reduce the severity, and frequency of relapses, of MULTIPLE SCLEROSIS. Unfortunately, there is little clear evidence that this interferon can affect the long-term outcome. In addition, it may cause an influenza-like effect for several months after starting treatment. Brand names are Avonex and Betaferon.

in·ter·fer·on be·ta

(intĕr-fēron bātă)
Interferon elaborated by fibroblasts and microphages.
Mentioned in ?
References in periodicals archive ?
The design of this study allowed us to compare the effect of omega-3 fatty acid supplementation both against placebo alone and in combination with interferon beta.
Omega-3 fatty acids 'not beneficial for multiple sclerosis sufferers'
We are pleased to be working with Maxygen on the production of their optimised interferon beta product candidate," said Hans Orstrom, senior vice president of Biopharmaceuticals at Biovitrum.
Biovitrum AB signs interferon beta material manufacturing agreement with Maxygen Inc
Currently, there are 10 Food and Drug Administration (FDA)-approved treatments for MS, including four interferon beta preparations, glatiramer acetate, natalizumab, fingolimod, mitoxantrone, teriflunomide, and dimethyl fumarate (DMF; Table 2).
Multiple sclerosis research: diagnostics, disease-modifying treatments, and emerging therapies
Interferon beta 1-a prefilled syringe, 12,000,000 iu in 0.
No.2072-2016 list - code 259 - interferon beta 1-a, prefilled syringe, 12,000,000 iu in 0.5 ml
The company expects to start pivotal testing in 2012 after the multiple ascending dose (MAD) trial demonstrated the potential for monthly treatment and suggested the increased tolerability of AZ01, a long-acting interferon beta, compared to other treatment options.
Allozyne reports encouraging Phase IB trial data on multiple sclerosis drug candidate
5 mg reduced the rate of brain atrophy, or brain volume loss, compared to interferon beta 1a IM over 12 months, irrespective of disease activity prior to study start as shown in an analysis of the pivotal Phase III TRANSFORMS study.
Novartis to showcase data on Gilenya in MS patients

Medical browser ?
Full browser ?